Session » Muscle Biology, Myositis & Myopathies Poster (0683–0722)
-
Abstract Number: 0683
Predictors of Rapidly Progressive Interstitial Lung Disease and Mortality in Patients with Autoantibodies Against Melanoma Differentiation-Associated Protein 5 Dermatomyositis
-
Abstract Number: 0684
Extended Report: Successful Treatment anti-MDA5 Antibody-positive Interstitial Lung Disease with Plasma Exchange Therapy
-
Abstract Number: 0685
Adipokines and Loss of Lean Mass Among Patients with Rheumatoid Arthritis
-
Abstract Number: 0686
Is It Useful to Assess Muscle Involvement with Positron Emission Tomography in Patients with Idiopathic Inflammatory Myositis? A Case-Control Study
-
Abstract Number: 0687
Clinical Features and Prognosis of a Large North American Cohort of Adult MDA5+ Dermatomyositis
-
Abstract Number: 0688
Standardized Prevalence Ratios of Cancer in Idiopathic Inflammatory Myositis
-
Abstract Number: 0689
Incidence, Prevalence, and Mortality of Dermatomyositis: A Population-based Cohort
-
Abstract Number: 0690
Impact of Achieving 2016 ACR/EULAR Response Criteria on Patient Centered Outcome Measures in Myositis
-
Abstract Number: 0691
Serum Cytokine Profiles of Patients with Adult Idiopathic Inflammatory Myopathy
-
Abstract Number: 0692
Immunophenotyping of Inclusion Body Myositis Blood T Cells: Pathogenic and Biomarker Implications
-
Abstract Number: 0693
Discovery of Antigen Specific CD4+ T Cells in Anti-HMGCR-positive Immune Mediated Necrotizing Myopathy
-
Abstract Number: 0694
Glucagon-like Peptide-1 Receptor Agonist Suppresses Muscle Fiber Necroptosis and Muscle Inflammation and Ameliorates Muscle Weakness in Experimental Polymyositis
-
Abstract Number: 0695
Safety and Tolerability of IVIg (Octagam 10%) in Patients with Active Dermatomyositis. Results of a Randomized, Double-Blind, Placebo-Controlled Phase III Trial
-
Abstract Number: 0696
Anti-Transcriptional Intermediary Factor 1-gamma Antibodies in Dermatomyositis with and Without Cancer – A Longitudinal Study
-
Abstract Number: 0697
Detection of Autoantibodies Against Muscle-Specific Four-and-a-Half-LIM Domain 1 (FHL1) in Inflammatory Myopathies: Results from a Single-Center Cohort
-
Abstract Number: 0698
Flow Cytometry and Sorting of Single Antibody Secreting Cells from Frozen Muscle Tissue
-
Abstract Number: 0699
Clinical Characteristics of Idiopathic Inflammatory Myositis Manifesting with Myoglobinuria: A 15 Year Retrospective Review
-
Abstract Number: 0700
Clinical Outcomes in Idiopathic Inflammatory Myositis Within the Military Health System: A 15 Year Retrospective Review
-
Abstract Number: 0701
Use and Yield of Computed Tomography as a Cancer Surveillance Method in Idiopathic Inflammatory Myositis
-
Abstract Number: 0702
Performance of Commercial Autoantibody Testing in Comparison to Recognized Gold Standards in Myositis Autoantibody Testing
-
Abstract Number: 0703
CD8 Positron Emission Tomography (PET/CT) Imaging with 89Zr-Df-IAB22M2C in Patients with Inclusion Body Myositis
-
Abstract Number: 0704
Anti-SSa/SSb and Ro52 and Interstitial Lung Disease in Idiopathic Inflammatory Myopathies
-
Abstract Number: 0705
Mitochondrial Calcification-Induced Inflammation in Human Skeletal Muscle and Immune Cells
-
Abstract Number: 0706
Mycophenolate Mofetil and Methotrexate Efficacy in Dermatomyositis
-
Abstract Number: 0707
Association of Pneumomediastinum with Poor Prognosis in Patients with Myositis-Associated Interstitial Lung Disease
-
Abstract Number: 0708
Cardiovascular Risk in Myositis Patients Compared to General Population – Preliminary Data from a Single-centre Cross-sectional Study
-
Abstract Number: 0709
Lower HDL-associated Apolipoprotein A-I Levels Associate with Presence of Calcinosis in Adult Dermatomyositis
-
Abstract Number: 0711
Suppression of HDL-associated Apolipoprotein A-I (apoA-I) Levels in Patients with Idiopathic Inflammatory Myopathies
-
Abstract Number: 0712
Immune Checkpoint Inhibitor-related Myotoxicity : Musculoskeletal and/or Neuromuscular Junction Disorder ?
-
Abstract Number: 0713
MDA5 Helicase Domains Identified as the Main Targets of Anti-MDA5 Autoantibodies in European Dermatomyositis Patients
-
Abstract Number: 0714
Diagnostic Accuracy of Electromyogram for Myositis
-
Abstract Number: 0715
High-Dimensional Analysis Reveals Abnormal B Cell Subsets Associated with Specific Changes to Circulating T and Myeloid Cell Populations in Patients with Idiopathic Inflammatory Myopathies
-
Abstract Number: 0716
Marked Capillary Basement Membrane Reduplication Is the Hallmark Histopathological Feature of Scleromyositis
-
Abstract Number: 0717
Association of Fatigue with Disease Activity in Myositis
-
Abstract Number: 0718
Pain Severity and Interference in Adult Autoimmune Inflammatory Myopathies
-
Abstract Number: 0719
Increased Risk of Venous Thromboembolism in Adult Patients with Idiopathic Inflammatory Myopathies
-
Abstract Number: 0720
The Clinical Significance of anti-PC4 and SFRS1 Interacting Protein 1 Antibody in Polymyositis and Dermatomyositis Patients
-
Abstract Number: 0721
Timed Function Tests as Measures of Disease Activity and Functional Outcome in Inflammatory Myositis
-
Abstract Number: 0722
Myostatin in Idiopathic Inflammatory Myopathies: Seric Assessment and Disease Activity